key: cord-348494-yx11ucrb
authors: Ali, Kamran; Raja, Mahwish
title: Coronavirus disease 2019 (COVID-19): challenges and management of aerosol-generating procedures in dentistry
date: 2020-06-26
journal: Evid Based Dent
DOI: 10.1038/s41432-020-0088-4
sha: 
doc_id: 348494
cord_uid: yx11ucrb

Data sources Experimental investigation. Study design A retrospective review to evaluate the use of a negative-pressure otolaryngology viral isolation drape (NOVID) system to reduce cross-infection through aerosol. The apparatus consists of a plastic drape suspended over the surgical field in the head and neck region with a smoke evacuator suction placed inside the chamber with an ultra-low penetrating air (ULPA) efficiency rating and a fluid suction high-efficiency particulate air (HEPA) filter compartment. Spread of patient secretions and droplet formation was evaluated using 1% fluorescein dye in 10 ml of normal saline and ultraviolet light. The dye was applied topically in the nasal cavity and nasopharynx preoperatively and intraoperatively prior to the use of instruments such as micro-debrider, electrocautery and high-speed drilling. Following completion of the surgical procedure, an ultraviolet Wood's lamp was used to evaluate the presence of droplets on the surgical drapes and surgical gowns of the operating team. Results The study sample consisted of four patients who underwent endonasal endoscopic surgical procedures; two of these patients required concurrent endoscopic sinus surgery. A micro-debrider was used in three cases; electrocautery in three cases, while a high-speed drilling was employed in two cases. Presence of fluorescein was identified around the patients' nares; on the chest wipe and instrument tray in all four patients. Dye contamination was noted on the gauze placed over the smoke evacuator (two cases of skull base surgery); no fluid droplets were identified beyond the nares or the smoke evacuator (two cases of sinus surgery). However, fluid contamination was identified underneath barrier several centimetres away from the nares (one case of trans-sphenoidal surgery). Droplets were also identified on the surgeon's gown in the abdominal region in all cases and on the arm region in one case. In one case, droplets were also identified on the abdominal region of the nurse, but this was attributed to cross contamination from surgical gauze and instruments. Conclusions This retrospective study provides preliminary data on aerosol and droplet contamination during endonasal and transoral surgery performed under a negative pressure isolation drape system. Although the authors did not screen patients for SARS-CoV-2, they propose smoke evacuator ULPA filter attachment is appropriate to capture particles down to 0.1 microns including SARS-CoV-2 which is 0.125 microns. It would be helpful to see direct evidence to support this claim in future studies. The authors have not provided details regarding set-up time and training requirements for effective application of the isolation drape apparatus or the associated costs etc. It would have also been helpful if the authors could comment on any potential difficulties in undertaking the surgical procedure with the isolation system in place. The sample size is limited to four patients and variations in the magnitude and extent of aerosol contamination needs to be investigated further before drawing any conclusions. Although unlikely, this study design did not capture the presence of aerosol/droplets in the air within the operating room which may follow removal of the isolation drape system or from exposed surgical instruments. Notwithstanding the limitations of the design, negative-pressure aspiration of air under a chamber barrier is likely to minimise the contamination from aerosol and droplet during endonasal and transoral surgery.

The study sample consisted of four patients who underwent endonasal endoscopic surgical procedures; two of these patients required concurrent endoscopic sinus surgery. A micro-debrider was used in three cases; electrocautery in three cases, while a high-speed drilling was employed in two cases. Presence of fluorescein was identified around the patients' nares; on the chest wipe and instrument tray in all four patients. Dye contamination was noted on the gauze placed over the smoke evacuator (two cases of skull base surgery); no fluid droplets were identified beyond the nares or the smoke evacuator (two cases of sinus surgery). However, fluid contamination was identified underneath barrier several centimetres away from the nares (one case of trans-sphenoidal surgery). Droplets were also identified on the surgeon's gown in the abdominal region in all cases and on the arm region in one case. In one case, droplets were also identified on the abdominal region of the nurse, but this was attributed to cross contamination from surgical gauze and instruments.

This retrospective study provides preliminary data on aerosol and droplet contamination during endonasal and transoral surgery performed under a negative pressure isolation drape system.

Although the authors did not screen patients for SARS-CoV-2, they propose smoke evacuator ULPA filter attachment is appropriate to capture particles down to 0.1 microns including SARS-CoV-2 which is 0.125 microns. It would be helpful to see direct evidence to support this claim in future studies. The authors have not provided details regarding set-up time and training requirements for effective application of the isolation drape apparatus or the associated costs etc. It would have also been helpful if the authors could comment on any potential difficulties in undertaking the surgical procedure with the isolation system in place. The sample size is limited to four patients and variations in the magnitude and extent of aerosol contamination needs to be investigated further before drawing any conclusions. Although unlikely, this study design did not capture the presence of aerosol/droplets in the air within the operating room which may follow removal of the isolation drape system or from exposed surgical instruments. Notwithstanding the limitations of the design, negative-pressure aspiration of air under a chamber barrier is likely to minimise the contamination from aerosol and droplet during endonasal and transoral surgery.

The coronavirus disease (COVID-19) caused by the novel coronavirus (SARS-CoV-2) has had an unprecedented impact on people across the globe. Even the most advanced healthcare systems in the world are still battling to deal with the challenges of COVID-19 and no single strategy to limit the spread of this pandemic appears to be sustainable. COVID-19 has posed serious tests for the political leadership across the globe due to the financial and social fallout and also exposed the vulnerabilities of modern healthcare infrastructures. The death rate from COVID-19 in the Western world including the USA, UK, France, Italy, and Spain etc, has been alarming 1 and has raised questions regarding our preparedness for managing pandemics.

Kamran Ali 1 and Mahwish Raja 2

• For now practitioners should focus on emergency and preventive dental care as evidence-based clinical protocols are needed prior to commencing invasive dental procedures

• Dental surgeries represent a potentially high-risk clinical environment and dental professionals must follow the most updated national and international guidelines in letter and spirit to protect themselves as well as their staff, patients, and the general public from further spread of COVID-19

• Additional costs related to PPE, staff training, and the investment to improve clinical environment coupled with low rates of patient turn-over will have a knock-on effect on the financial resources of dental businesses. Therefore, governments and healthcare bodies must be urged to come up with concrete strategies to support the dental profession and keep dental practices financially viable

• Finally, dental professionals should not remain at the receiving end of cross infection control guidelines and should explore appropriate platforms to actively participate in research aimed at informing evidence-based protocols to limit the spread of COVID-19 in dental environments.

Unsurprisingly povidone-iodine or 0.5-1% hydrogen peroxide may also be utilised preoperatively to reduce the viral load in the oral cavity. 10, 11 The use of NOVID system offers promise to limit contamination from aerosol during surgical procedures performed under general anaesthesia in operating theatre environments. Although use of this device on conscious patients in dental practice settings is unlikely in its current form, it opens doors to innovation in the development of barrier systems. In any case, dentists may benefit from evaluating the spread on aerosol during operative dentistry by using fluorescein dye and ultraviolet (UV) light as identified in this study.

Given our current understanding, COVID-19 may be around for the coming months or even years, and is likely to influence the provision of dental care in more ways than one. The best-case scenario is development of an effective vaccine and coupled with universal precautions, life in dentistry may return to normal. Until then, we are likely to be presented with a plethora of strategies and measures aimed at minimising the spread of COVID-19 in clinical dental settings.

These may include innovations in PPE; barrier devices to minimise aerosol contamination; air purification systems; anti-viral adjuncts;

chairside screening for COVID-19 in saliva; and modifications in clinical techniques, to name a few. Undoubtedly, commercial players in the dental market will be interested to exploit these business opportunities as dentistry attempts to resume. Therefore, dental professionals must make informed choices supported by scientific evidence. On the plus side, COVID-19 presents an opportunity for dental professionals to diversify their career interests and explore their research potential through engagement with relevant research forums and platforms. Cross infection protocols in dentistry are likely to undergo rapid evolution and dental professionals must contribute to this process rather than wait to be told what to do! 

WHO. Coronavirus disease (COVID-2019) situation reports. Available at

Virtual screening, and repurposing of FDA approved drugs against COVID-19 main protease

Remdesivir for COVID-19: challenges of underpowered studies

Evidence of Increasing Diversification of Emerging SARS-CoV-2 Strains

What policy makers need to know about COVID-19 protective immunity

Transmission of coronavirus disease 2019 (COVID19)

Transmission routes of 2019-nCoV and controls in dental practice

The oral surgery response to coronavirus disease (COVID-19)

Inactivation of SARS coronavirus by means of povidoneiodine, physical conditions, and chemical reagents

Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents